CGS International Adjusts Paragon REIT's Price Target to SG$0.85 From SG$0.86, Keeps at Hold
UOB Kay Hian Upgrades Orient Overseas (International) to Hold From Sell, Price Target Is HK$132.20
Analysts' Top Healthcare Picks: Merck KGaA (GB:0O14), Paragon Care Limited (DE:PXS)
Analysts Offer Insights on Industrial Goods Companies: Boeing (BA), Carlisle Companies (CSL) and Orient Overseas (International) (OtherOROVF)
Paragon 28 Analyst Ratings
Paragon 28 (FNA) Gets a Buy From Piper Sandler
Paragon 28 Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Zentalis Pharmaceuticals (ZNTL) and Paragon 28 (FNA)
Paragon 28's Sustained Growth and Strategic Initiatives Bolster Buy Rating
Analysts Are Bullish on These Healthcare Stocks: Paragon 28 (FNA), Prothena (PRTA)
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Paragon 28 (FNA) and Intra-Cellular Therapies (ITCI)
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
Maintaining a Buy: Paragon 28's Strong Q1 Performance and Optimistic Financial Outlook Despite CFO Transition
Paragon 28 Analyst Ratings
Analysts' Top Healthcare Picks: Paragon 28 (FNA), Genmab (GMAB)
Buy Rating Affirmed for Paragon 28 on Strategic Product Launches and Strong Market Position
Paragon 28 Analyst Ratings
Needham Reiterates Buy on Paragon 28, Maintains $17 Price Target
Paragon 28 Analyst Ratings
Piper Sandler Keeps Their Buy Rating on Paragon 28 (FNA)